These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3733116)

  • 1. Effect of purgatives on antidotal efficacy of oral activated charcoal.
    Neuvonen PJ; Olkkola KT
    Hum Toxicol; 1986 Jul; 5(4):255-63. PubMed ID: 3733116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do gastric contents modify antidotal efficacy of oral activated charcoal?
    Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1984 Nov; 18(5):663-9. PubMed ID: 6508975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM; Caraccio TR; Lovejoy FH
    Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of magnesium citrate and clidinium bromide on the excretion of activated charcoal in normal subjects.
    Vuignier BI; Oderda GM; Gorman RL; Klein-Schwartz W; Watson WA
    DICP; 1989 Jan; 23(1):26-9. PubMed ID: 2718479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saline cathartics and saline cathartics plus activated charcoal as antidotal treatments.
    Chin L; Picchioni AL; Gillespie T
    Clin Toxicol; 1981 Jul; 18(7):865-71. PubMed ID: 7332642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal transit times of cathartics combined with charcoal.
    Krenzelok EP; Keller R; Stewart RD
    Ann Emerg Med; 1985 Dec; 14(12):1152-5. PubMed ID: 4061985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated charcoal-carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin.
    Mathur LK; Jaffe JM; Colaizzi JL; Moriarty RW
    Am J Hosp Pharm; 1976 Jul; 33(7):717-9. PubMed ID: 941924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil.
    Laine K; Kivistö KT; Neuvonen PJ
    J Toxicol Clin Toxicol; 1997; 35(3):263-8. PubMed ID: 9140320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of whole-bowel irrigation on the antidotal efficacy of oral activated charcoal.
    Rosenberg PJ; Livingstone DJ; McLellan BA
    Ann Emerg Med; 1988 Jul; 17(7):681-3. PubMed ID: 3382069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
    Levy G; Soda DM; Lampman TA
    Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Sodium Picosulfate/Magnesium Citrate for Bowel Preparation in a Physically Disabled Outpatient Population: A Randomized, Endoscopist-Blinded Comparison With Ascorbic Acid-Enriched Polyethylene Glycol Solution Plus Bisacodyl (The PICO-MOVI Study).
    Mathus-Vliegen EMH; van der Vliet K; Wignand-van der Storm IJ; Stadwijk JS
    Dis Colon Rectum; 2018 Feb; 61(2):239-249. PubMed ID: 29337780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal transit times of cathartics used with activated charcoal.
    Krenzelok EP
    Clin Pharm; 1985; 4(4):446-8. PubMed ID: 4042559
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
    Curtis RA; Barone J; Giacona N
    Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration.
    Laine K; Kivistö KT; Pelttari S; Neuvonen PJ
    Pharmacol Toxicol; 1996 Nov; 79(5):270-3. PubMed ID: 8936562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT; Lee YJ; Chung SJ; Shim CK
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man.
    Olkkola KT
    Br J Clin Pharmacol; 1985 Jun; 19(6):767-73. PubMed ID: 4027120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of saline cathartics on gastrointestinal transit time of activated charcoal.
    Orisakwe OE; Ogbonna E
    Hum Exp Toxicol; 1993 Sep; 12(5):403-5. PubMed ID: 7902117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of activated charcoal on the pharmacokinetics of pholcodine, with special reference to delayed charcoal ingestion.
    Laine K; Kivistö KT; Ojala-Karlsson P; Neuvonen PJ
    Ther Drug Monit; 1997 Feb; 19(1):46-50. PubMed ID: 9029746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preadministration of activated charcoal and aspirin absorption.
    McKinney PE; Gillilan R; Watson WA
    J Toxicol Clin Toxicol; 1992; 30(4):549-56. PubMed ID: 1433426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
    Scholtz EC; Jaffe JM; Colaizzi JL
    Am J Hosp Pharm; 1978 Nov; 35(11):1355-9. PubMed ID: 707504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.